Keyword Search
Keyword=cancer


The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2002 Program page



  300177  By:  Joseph P. Costantino 9:35 AM 08/14/2002
Risk Assessment Modeling in Clinical Trials

  300126  By:  James L. Kepner 4:30 PM 08/11/2002
Statistical Issues in Clinical Trials for Children with Cancer

  300039  By:  Andrea B. Troxel 2:05 PM 08/14/2002
Measuring Sensitivity to Nonignorable Dropout in the Analysis of Quality-of-Life Data

  300486  By:  Kao-Tai  Tsai 3:35 PM 08/12/2002
Q-TWiST Analysis for Neoadjuvant Cancer Trials

  300527  By:  Debashis  Ghosh 9:35 AM 08/15/2002
Meta-analysis of Microarray Data for Prostate Cancer Studies

  300496  By:  Heping  Zhang 11:00 AM 08/14/2002
Cell and Tumor Classifications Using Gene Expression Data: Forests Versus Trees

  300660  By:  Diane L. Fairclough 11:55 AM 08/13/2002
Contrasting Three Models for Non-Ignorable Missing Quality-Of-Life Data In Non-Small Cell Lung Cancer Patients

  300714  By:  Harry J. Norton 10:35 AM 08/15/2002
The Will Rogers Phenomenon: What is it and how did it get its name?

  300817  By:  Dawei  Xie 4:05 PM 08/11/2002
Combining Surveys to Estimate Cancer Risk Factors in Small Areas

  300827  By:  Rodney  Sparapani 08/13/2002
Poster # 23   Hospital Volume and Quality of Care in Breast Cancer Surgery

  300828  By:  Feng  Tang 8:50 AM 08/12/2002
Designing Dose Individualization for Transplant Anti-Cancer Therapy Based on Bayesian Population Pharmacokinetic Model

  300848  By:  Jane  Fridlyand 10:35 AM 08/15/2002
Applications of Re-sampling Methods for the Cluster Analysis

  301028  By:  Qiuhu  Shi 3:20 PM 08/11/2002
Minimize the Jackknife Estimate of the Bias to Select the Smallest Genes Set to Identify Case and Control

  300377  By:  Stephanie R. Land 9:35 AM 08/12/2002
Assessment and Analysis of QOL Outcomes in Cancer Clinical Trials: The NSABP Experience

  301405  By:  Bradley  Carlin 2:35 PM 08/14/2002
Using Hierarchical Spatial Models for Cancer Control Planning in Minnesota

  301463  By:  Dirk F. Moore 2:50 PM 08/12/2002
Predicting the Future Profile of Prostate-specific Antigen Levels Following Radiation Therapy for Prostate Cancer.

  301477  By:  Gang  Li 8:35 AM 08/14/2002
A Joint Hierarchical Model Approach for Competing Risk Analysis in Analyzing Different Types of Cancer Mortality

  301577  By:  Margaret G. Conomos 8:50 AM 08/12/2002
Investigating Cancer Mortality and Environmental Statistics on Toxic Releases: A Geographical Information Analysis

  301797  By:  Yingye  Zheng 2:20 PM 08/11/2002
Verification Bias in Assessment of Mammography Accuracy

  301865  By:  Gary L. Rosner 11:50 AM 08/12/2002
An Aid to Monitoring Phase II Studies in Cancer

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002